HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

PRF Payments Applicable to Lost Revenue Based on Formal Budgets

February 3, 2021 by Andrea Stark

Provider Relief Fund (PRF) payments to losses based on the organization’s budget-to-actual revenue. Before the passage of the Consolidated Appropriations Act (2021), reporting rules required suppliers to compare actual revenues for 2019 and 2020 to determine eligible losses for PRF payments.

In general, current guidance still requires suppliers without formal budgets, or without evidence of budget approval prior to March 27, 2020, to calculate revenue losses based on actual year-over-year comparisons. In its January Post-Payment Notice of Reporting Requirements, however, the Health Resources and Services Administration (HRSA) opened the door to reasonable alternative methods of calculating lost revenue. HRSA is the agency HHS chose to administer the Provider Relief Fund.

The latest HRSA guidance marks the fourth revision to lost revenue calculations for PRF reporting. The following timeline shows the evolution from the initial rules:

  • September 19, 2020. The September instructions capped the use of lost revenues to an amount that would not make the organization more profitable in 2020 than 2019.
  • October 22, 2020. The October revision reversed the profitability clause so providers could apply PRF payments against all lost revenue, net of healthcare expenses, without limitation.
  • November 2, 2020. The November revision removed the net-of-healthcare expenses language so providers could apply PRF payments to all lost revenue without limitation. As a result, suppliers calculated lost revenue independent of increased expenses.
  • January 15, 2021. The latest guidance incorporates the congressionally-mandated change to permit budgeted revenue projections as a viable input for lost revenue calculations. Moreover, suppliers may use other reasonable alternative methods of estimating lost revenue, though the HRSA will likely audit those choosing an alternate method.

Each subsequent revision clarifies the lost revenue calculation, but suppliers should not confuse clarification with advantage or gain. Individual circumstances will factor heavily into the amount of Provider Relief Fund dollars suppliers can earn, and as a result, some suppliers will have to return a portion of the funds they received.

As a reminder, suppliers that accepted over $10,000 in Provider Relief Funds agreed to terms and conditions which mandate reporting on the use of funds. The current 7-page post-payment notice contains many more details about which expenses and revenues qualify for reporting purposes. Because applicability and circumstances vary by company, we strongly advise suppliers work closely with a certified public accountant or knowledgeable accounting professional to ensure accurate reporting and application of the guidelines.

Source Links:
https://www.congress.gov/116/bills/hr133/BILLS-116hr133enr.pdf (Page 740)
https://www.hhs.gov/sites/default/files/provider-post-payment-notice-of-reporting-requirements-january-2021.pdf
https://www.hhs.gov/sites/default/files/post-payment-notice-of-reporting-requirements.pdf
https://www.hhs.gov/sites/default/files/post-payment-notice-of-reporting-requirements-october-2020.pdf
https://www.hhs.gov/sites/default/files/post-payment-notice-of-reporting-requirements-november-2020.pdf

Related Articles Read More >

DMEPOS Competitive Bidding: What We Know So Far
Product category inclusions and exclusions, and the potential impact on home medical equipment providers.
CQRC ‘Commends’ Exclusions of Supplemental Oxygen, CPAP from Medicare Competitive Bidding
The Council for Quality Respiratory Care also urged industry support for the SOAR act.
AOPA: Final Rule to Have ‘Significant Impact’ on Orthotics, Prosthetics Providers
OTS knee, spinal and upper-extremity orthoses are included in the remote item delivery portion of the competitive bidding program.
Resmed Announces FDA Clearance for AI Device to Support Sleep Therapy Regimens
The device incorporates artificial intelligence and will be marketed as Smart Comfort.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe